Page 30 - 南京医科大学自然版
P. 30

第46卷第9期
               ·1300 ·                           南 京    医 科 大 学 学         报                        2026年9月


              review,and publication decisions were conducted independently  clinical benefits in trials of disease⁃modifying therapies
              and with academic integrity.                           for type 1 diabetes[J]. Diabetes,2024,73(6):823-833
                  作者贡献声明:                                       [11] LOPES V,SOUSA M E,LOPES S C,et al. Metabolic
                  胡羽珊负责文献收集、阅读、整理和论文初稿撰写;王远                          impact of residual C⁃peptide secretion in type 1 diabetes
              远参与文献核对、论文修改;潘寅兵提出研究想法、进行论文                            mellitus[J]. Arch Endocrinol Metab,2024,68:e230503
              审阅与修改。                                            [12] JEYAM A,COLHOUN H,MCGURNAGHAN S,et al.
                  Author’s Contributions:                            Clinical impact of residual C⁃peptide secretion in type 1
                  HU Yushan was responsible for collecting,reading,organiz⁃  diabetes on glycemia and microvascular complications[J].
              ing the literature and writing the initial draft of the thesis;  Diabetes Care,2021,44(2):390-398
              WANG Yuanyuan participated in verifying the literature and  [13] YARIBEYGI H,MALEKI M,SATHYAPALAN T,et al.
              revising the thesis;PAN Yinbing proposed the research ideas  The effect of C⁃peptide on diabetic nephropathy:a review
              and conducted the review and revision of the thesis.   of molecular mechanisms[J]. Life Sci,2019,237:116950
             [参考文献]                                             [14] BRUNSKILL N J. C⁃peptide and diabetic kidney dis⁃
                                                                     ease[J]. J Intern Med,2017,281(1):41-51
             [1] DIANNA J M,EDWARD J B. IDF diabetes atlas 10th
                                                                [15]SHAW J A,SHETTY P,BURNS K D,et al. C⁃peptide as
                   edition scientific committee[M]. Brussels:International
                                                                     a therapy for kidney disease:a systematic review and
                   Diabetes Federation,2021
                                                                     meta⁃analysis[J]. PLoS One,2015,10(5):e0127439
             [2] ALBERS J W,POP⁃BUSUI R. Diabetic neuropathy:mech⁃
                                                                [16]LEE A J,MOON C H,LEE Y J,et al. Systemic C⁃peptide
                   anisms,emerging treatments,and subtypes[J]. Curr Neurol
                                                                     supplementation ameliorates retinal neurodegeneration
                   Neurosci Rep,2014,14(8):473
                                                                     by inhibiting VEGF⁃induced pathological events in diabe⁃
             [3] LIU X X,XU Y Y,AN M M,et al. The risk factors for
                                                                     tes[J]. FASEB J,2023,37(2):e22763
                   diabetic peripheral neuropathy:a meta⁃analysis[J]. PLoS
                                                                [17]PERMUTT M A,KIPNIS D M. Insulin biosynthesis:studies
                   One,2019,14(2):e0212574
                                                                     of Islet polyribosomes(nascent peptides ⁃ sucrose gradient
             [4] BAXI H,HABIB A,HUSSAIN M S,et al. Prevalence of
                                                                     analysis ⁃ gel filtration)[J]. Proc Natl Acad Sci U S A,
                   peripheral neuropathy and associated pain in patients
                                                                     1972,69(2):505-509
                   with diabetes mellitus:evidence from a cross ⁃ sectional
                                                                [18]STEINER D F,OYER P E. The biosynthesis of insulin and
                   study[J]. J Diabetes Metab Disord,2020,19(2):1011-1017
                                                                     a probable precursor of insulin by a human islet cell adeno⁃
             [5] TAO Y,ZHANG H Y,MACGILCHRIST C,et al. Preva⁃
                                                                     ma[J]. Proc Natl Acad Sci U S A,1967,57(2):473-480
                   lence and risk factors of painful diabetic neuropathy:a
                                                                [19]HOWELL S L. Role of ATP in the intracellular translo⁃
                   systematic review and meta ⁃ analysis[J]. Diabetes Res
                                                                     cation of proinsulin and insulin in the rat pancreatic B
                   Clin Pract,2025,222:112099
             [6] TESFAYE S,BOULTON A J,DYCK P J,et al. Diabetic      cell[J]. Nat New Biol,1972,235(55):85-86
                   neuropathies:update on definitions,diagnostic criteria,  [20]HOWELL S L,KOSTIANOVSKY M,LACY P E. Beta
                   estimation of severity,and treatments[J]. Diabetes Care,  granule formation in isolated islets of Langerhans:a study
                                                                     by electron microscopic radioautography[J]. J Cell Biol,
                   2010,33(10):2285-2293
             [7] DACOSTA DIBONAVENTURA M,CAPPELLERI J C,             1969,42(3):695-705
                   JOSHI A V. A longitudinal assessment of painful diabetic  [21]KEMMLER W,PETERSON J D,STEINER D F. Studies
                                                                     on the conversion of proinsulin to insulin.I. Conversion in
                   peripheral neuropathy on health status,productivity,and
                   health care utilization and cost[J]. Pain Med,2011,12  vitro with trypsin and carboxypeptidase B[J]. J Biol Chem,
                  (1):118-126                                        1971,246(22):6786-6791
             [8] NARANJOC,DEL REGUEROL,MORATALLAG,et al.        [22]OYER P E,CHO S,PETERSON J D,et al. Studies on
                   Anxiety,depression and sleep disorders in patients with  human proinsulin. Isolation and amino acid sequence of
                   diabetic neuropathic pain:a systematic review[J]. Expert  the human pancreatic C⁃peptide[J]. J Biol Chem,1971,
                   Rev Neurother,2019,19(12):1201-1209               246(5):1375-1386
             [9] SELVARAJAH D,CASH T,SANKAR A,et al. The con⁃   [23]HORWITZ D L,STARR J I,MAKO M E,et al. Proinsu⁃
                   tributors of emotional distress in painful diabetic neuropa⁃  lin,insulin,and C⁃peptide concentrations in human portal
                   thy[J]. Diab Vasc Dis Res,2014,11(4):218-225      and peripheral blood[J]. J Clin Invest,1975,55(6):
             [10] LATRES E,GREENBAUM C J,OYASKI M L,et al.           1278-1283
                   Evidence for C⁃peptide as a validated surrogate to predict  [24]HENRIKSSON M,SHAFQAT J,LIEPINSH E,et al. Un⁃
   25   26   27   28   29   30   31   32   33   34   35